COVID-19 Pandemic in Haryana
DiseaseCOVID-19
Virus strainSARS-CoV-2
LocationHaryana, India
First outbreakWuhan, China
Index caseGurugram
Arrival date4 March 2020
(4 years, 2 months, 3 weeks and 3 days)
Confirmed casesNegative increase 2,64,955
Active casesPositive decrease 2,510
RecoveredIncrease 2,59,495
Deaths
Negative increase 2,950
Territories
22 out of 22 districts
Government website
www.mohfw.gov.in

The first case of the COVID-19 pandemic in the Indian state of Haryana was reported on 4 March 2020.[1] The Ministry of Health and Family Welfare has confirmed a total of 2,64,955 positive cases as of 10 January 2021 out of which 2,510 are still active and 2,950 deaths so far. The recovery rate in Haryana is 97.9%.[2]

Statistics

Charts

Data reference:[3][failed verification]

Graphs are unavailable due to technical issues. There is more info on Phabricator and on MediaWiki.org.
Graphs are unavailable due to technical issues. There is more info on Phabricator and on MediaWiki.org.
Graphs are unavailable due to technical issues. There is more info on Phabricator and on MediaWiki.org.
Graphs are unavailable due to technical issues. There is more info on Phabricator and on MediaWiki.org.

Testing and countermeasures

Testing facilities

Six (8) labs, one each at PGIMS, Rohtak, BPS Khanpur Kalan, Sonipat, ESIC Hospital, Faridabad, Kalpana Chawla Medical College, Karnal, ICAR-National Research Centre on Equines, Hisar, PGIMER Chandigarh, CSIR Mohali, Civil Hospital, Panchkula are already functional for testing of COVID-19. Five private labs at Gurugram (Modern Diagnostics and Research Lab, SRL, CORE Diagnostics, Pathkind Diagnostics Pvt. Ltd., Dr. Lal Pathlabs) approved by ICMR for COVID-19 testing.

Hospital facilities

6 government/ aided medical colleges namely PGIMS in Rohtak, BPSGMC in Khanpur Kalan (Sonepat), SHKMGMC in Nalhar, Nuh, KCGMC, Karnal, MAMC, Agroha and 27 hospitals will have dedicated exclusive wards/blocks for COVID-19 patients only. ESIC Medical College, Faridabad is under process for COVID-19 hospital.

All government/ government aided/ private medical colleges in the state have been asked to reserve at least 25% of the beds.

Isolation wards and quarantine facilities are established as given below:

34,876 isolation beds identified in 601 government and private facilities.

21,188 persons quarantine facility identified in 6133 rooms/dormitories.

Timeline

July 2020

August 2020

September 2020

October 2020

November 2020

December 2020

January 2021

February 2021

March 2021

April 2021

May 2021

7 MAY,2021

June 2021

July 2021

August 2021

September 2021

Oct to Dec 2021

Jan to Mar 2022

Apr to Jun 2022

July to September 2022

COVID-19 vaccines with approval for emergency or conditional usage

Union Minister for Health & Family Welfare, Dr. Harsh Vardhan visiting the GTB Hospital, Shahdara to review the preparedness of dry run of COVID-19 vaccine, in Delhi on January 2, 2021.

Main article: COVID-19 vaccine

Covishield

On January 1, 2021, the Drug Controller General of India, approved the emergency or conditional use of AstraZeneca's COVID-19 vaccine AZD1222 (marketed as Covishield).[9] Covishield is developed by the University of Oxford and its spin-out company, Vaccitech.[10] It is a viral vector vaccine based on replication-deficient adenovirus that causes cold in chimpanzees. It can be stored, transported and handled at normal refrigerated conditions (28 degrees Celsius/ 36-46 degrees Fahrenheit). It has a shelf-life of at least six months.

On 12 January 2021 first batches of Covishield vaccine was despatched from the Serum Institute of India.[11]

Covaxin

On January 2, 2021, BBV152 (marketed as Covaxin), first indigenous vaccine, developed by Bharat Biotech in association with the Indian Council of Medical Research and National Institute of Virology received approval from the Drug Controller General of India for its emergency or conditional usage.[12]

On 14 January 2021 first batches of Covaxin vaccine was despatched from the Bharat Biotech, albeit it was still in the third phase of testing.[13]

Others

On 19 May 2021, Dr Reddy's Labs received Emergency Use Authorisation for anti-COVID drug 2-DG.[14] On 21 February, 2022, Drugs Controller General of India granted approval to Biological E's COVID-19 vaccine Corbevax, that can be used for children between 12 and 18 years of age.[15][16]

On 21 October 2021, India completed administering of one billion Covid vaccines in the country.[17]

On 8 January 2022, India crossed 1.5 billion Covid vaccines milestone in the country.[18]

On 19 February 2022, India crossed 1.75 billion Covid vaccines milestone in the country.[19]

See also

References

  1. ^ "Haryana's first coronavirus positive case reported in Gurugram". Hindustan Times. 16 March 2020.
  2. ^ "NHMHry | Home". www.nhmharyana.gov.in. Archived from the original on 7 March 2021. Retrieved 5 June 2020.
  3. ^ "Harasdesh". haraadesh.nic.in.
  4. ^ Verma, Chetan (10 July 2020). "Haryana : कोरोना के 565 नए केस, तीन मौतें | Hari Bhoomi". www.haribhoomi.com.
  5. ^ "National Health Mission, Haryana". www.nhmharyana.gov.in. Archived from the original on 7 March 2021. Retrieved 7 May 2020.
  6. ^ a b c d e f g h i j k l m n o p q r s t u v w x y z aa ab ac ad ae af ag ah ai aj ak al am an ao ap aq ar as at au av aw ax ay az ba bb bc bd be bf "MoHFW-GOI". Ministry of Health and Family Welfare. Retrieved 23 May 2020.
  7. ^ "Haryana crosses one lakh COVID-19 cases". New Indian Express. Retrieved 22 September 2020.
  8. ^ a b c d e f g h i j k l m n o p q r s "COVID19 STATEWISE STATUS". MyGov.in. 28 March 2020. Retrieved 4 December 2021.
  9. ^ "COVID-19 vaccine Covishield gets approval from DCGI's expert panel". The Hindu. 1 January 2021. Retrieved 4 January 2021.
  10. ^ "AstraZeneca's COVID-19 vaccine authorised for emergency supply in the UK". AstraZeneca. AstraZeneca. 30 December 2020. Retrieved 4 January 2021.
  11. ^ "Stand By, India: Serum Institute Sends Out Vaccines, 1st Batch In Delhi". NDTV. 12 January 2021. Retrieved 12 January 2021.
  12. ^ "Expert panel recommends Bharat Biotech's Covaxin for restricted emergency use". News18. 2 January 2021. Retrieved 4 January 2021.
  13. ^ "Covaxin delivery starts, 'full initial procurement allotted'". Indian Express. 14 January 2021. Retrieved 14 January 2021.
  14. ^ "Dr Reddy's confirms Emergency Use Authorisation for anti-COVID drug 2-DG, says price not yet fixed". Moneycontol. 19 May 2021. Retrieved 20 May 2021.
  15. ^ "Approval granted to COVID vaccine Corbevax for children between 12-18 years". Times of India. 21 February 2022. Retrieved 22 February 2022.
  16. ^ "Biological E's Covid vaccine Corbevax receives emergency use nod for children aged 12-18 yrs". Hindustan Times. 21 February 2022. Retrieved 22 February 2022.
  17. ^ "India scripts history, administers one billion Covid-19 vaccine doses". Hindustan Times. 21 October 2021. Retrieved 27 October 2021.
  18. ^ "India crosses 1.5 bn Covid vaccine doses, Modi terms it 'significant milestone'". Hindustan Times. 9 January 2022. Retrieved 9 January 2022.
  19. ^ "COVID-19: India's vaccination coverage crosses 175 crore mark". DNA India. 19 February 2022. Retrieved 26 February 2022.